A hypothetical intervention on the use of hearing aids for the risk of dementia in people with hearing loss in UK Biobank - Top-Institutions - MDSpire

A hypothetical intervention on the use of hearing aids for the risk of dementia in people with hearing loss in UK Biobank

  • By

  • Jure Mur

  • Matthias Klee

  • Helen R Wright

  • Alina Solomon

  • Christine Johnson

  • Thomas J Littlejohns

  • Graciela Muniz-Terrera

  • Anja K Leist

  • December 16, 2024

  • 0 min

Share

Top Institutions in Neurology

Brief introduction explaining scope and methodology.

  • #1

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Geriatrics
    • Audiology
    • Neurology
    • Epidemiology

  • #2

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Neurology
    • Audiology
    • Geriatrics

  • #3

    University College London (UCL)
    University College London (UCL)

    London, England

    Key Differentiators

    • Epidemiology
    • Audiology
    • Neurology

  • #4

    Massachusetts General Hospital (MGH) / Harvard Medical School
    Massachusetts General Hospital (MGH) / Harvard Medical School

    Boston, MA

    Key Differentiators

    • Neurology
    • Audiology
    • Geriatrics

  • #5

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Geriatrics
    • Audiology
    • Neurology

Original Source(s)

A hypothetical intervention on the use of hearing aids for the risk of dementia in people with hearing loss in UK Biobank

  • by Jure Mur, Matthias Klee, Helen R Wright, Alina Solomon, Christine Johnson, Thomas J Littlejohns, Graciela Muniz-Terrera, Anja K Leist

  • December 16, 2024

Related Content

Can Lower Music Levels Preserve Workout Intensity?

Despite preserved exertion perceptions, researchers report limited hearing protection use in group fitness classes.

Molecular signatures and biomarker development for limbic-predominant age-related TDP-43 encephalopathy (LATE)

This Week’s CGT News: CAR-T Breaks New Ground in Alzheimer’s

First CAR-T approach for Alzheimer’s reduces amyloid plaques in mice, while cell and gene therapies advance across blood cancers, retinal disease, amyloidosis, and FSHD

  • May 11, 2026

  • 7 min